Decibel Cannabis Co Inc (DBCCF)
0.0415
-0.01
(-14.78%)
USD |
OTCM |
Sep 27, 16:00
Decibel Cannabis Enterprise Value: 44.15M for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
September 27, 2024 | 44.15M |
September 26, 2024 | 47.09M |
September 25, 2024 | 45.58M |
September 24, 2024 | 45.58M |
September 23, 2024 | 46.53M |
September 20, 2024 | 49.24M |
September 19, 2024 | 48.95M |
September 18, 2024 | 48.40M |
September 17, 2024 | 48.40M |
September 16, 2024 | 47.54M |
September 13, 2024 | 47.56M |
September 12, 2024 | 47.01M |
September 11, 2024 | 46.93M |
September 10, 2024 | 45.58M |
September 09, 2024 | 47.34M |
September 06, 2024 | 46.97M |
September 05, 2024 | 48.36M |
September 04, 2024 | 48.50M |
September 03, 2024 | 49.22M |
August 30, 2024 | 46.72M |
August 29, 2024 | 46.49M |
August 28, 2024 | 45.58M |
August 27, 2024 | 46.23M |
August 26, 2024 | 48.02M |
August 23, 2024 | 47.62M |
Date | Value |
---|---|
August 22, 2024 | 48.03M |
August 21, 2024 | 51.55M |
August 20, 2024 | 51.37M |
August 19, 2024 | 48.73M |
August 16, 2024 | 47.62M |
August 15, 2024 | 43.33M |
August 14, 2024 | 40.06M |
August 13, 2024 | 42.10M |
August 12, 2024 | 43.08M |
August 09, 2024 | 43.49M |
August 08, 2024 | 44.35M |
August 07, 2024 | 43.74M |
August 06, 2024 | 43.59M |
August 05, 2024 | 42.75M |
August 02, 2024 | 43.82M |
August 01, 2024 | 45.00M |
July 31, 2024 | 44.34M |
July 30, 2024 | 43.53M |
July 29, 2024 | 43.61M |
July 26, 2024 | 43.45M |
July 25, 2024 | 44.49M |
July 24, 2024 | 44.76M |
July 23, 2024 | 45.17M |
July 22, 2024 | 43.94M |
July 19, 2024 | 42.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
25.84M
Minimum
Nov 18 2019
133.57M
Maximum
Aug 23 2021
65.95M
Average
65.67M
Median
Enterprise Value Benchmarks
Acasti Pharma Inc | 12.23M |
Aurinia Pharmaceuticals Inc | 710.50M |
Edesa Biotech Inc | 11.89M |
Lexaria Bioscience Corp | 38.87M |
Xenon Pharmaceuticals Inc | 2.207B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 0.0891M |
Revenue (Quarterly) | 16.19M |
Total Expenses (Quarterly) | 15.42M |
EPS Diluted (Quarterly) | 0.0002 |
Gross Profit Margin (Quarterly) | 39.72% |
Profit Margin (Quarterly) | 0.55% |
Earnings Yield | -17.64% |
Operating Earnings Yield | 27.91% |
Normalized Earnings Yield | 14.16 |